NCT04293081View on ClinicalTrials.gov

Preemptive Chlorepheniramine Maleate Reducing Postoperative Agitation

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 16, 2019

Primary Completion Date

May 31, 2019

Study Completion Date

July 30, 2019

Conditions
Agitated; State, Acute Reaction to Stress
Interventions
DRUG

Preemptive chlorepheniramine maleate intravenous injection

Participants of group A will receive only one ampoule of 45.5 mg/ 2mL chlorepheniramine maleate diluted in 8 ml isotonic saline intravenous (I.V) prior to induction of general anesthesia by 30 minutes

DRUG

normal saline

participants in group (B) will receive 10 ml isotonic saline (placebo) by the same route as control.

Trial Locations (1)

11591

AinShams University, Faculty of medicine, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04293081 - Preemptive Chlorepheniramine Maleate Reducing Postoperative Agitation | Biotech Hunter | Biotech Hunter